Announcements Trials

Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 73 Colonic Neoplasms 14 Rectal Neoplasms 13 Neoplasm Metastasis 12 Stomach Neoplasms 8 Pancreatic Neoplasms 5 Advanced Solid Tumors 5 Neoplasms 4 Colorectal Cancer Metastatic 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Gallbladder Neoplasms 3 Cholangiocarcinoma 3 Carcinoma 3 Adenocarcinoma 3 Neutropenia 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Biliary Tract Neoplasms 2 Bile Duct Neoplasms 2 Advanced Solid Tumors (Excluding Breast Cancer) 2 Advanced Colorectal Cancer 2 Adenocarcinoma Of Esophagus 2 mCRC 1 Urologic Diseases 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Spinocerebellar Degenerations 1 Solid Tumor Cancer 1 Solid Tumor 1

Interventions

pembrolizumab 14 Injections 13 Paclitaxel 10 Nivolumab 10 Docetaxel 9 Cisplatin 9 Capecitabine 9 Bevacizumab 8 toripalimab 7 senaparib 7 Fluorodeoxyglucose F18 7 Cyclophosphamide 7 tislelizumab 6 atezolizumab 6 Irinotecan 6 Fluorouracil 6 Gemcitabine 5 fludarabine 4 apatinib 4 Oxaliplatin 4 Leucovorin 4 Ipilimumab 4 Carboplatin 4 spartalizumab 3 sintilimab 3 pertuzumab 3 olaparib 3 camrelizumab 3 Rifampin 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × trifluridine tipiracil drug combination × Clear all

NCT04260269 2024-12-12

CardioSwitch

Helsinki University Central Hospital

Enrolling by invitation

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡